Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA #sort ascending PI/Project Leader Institution Title Status
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Active
2019 R43 PAR-18-303 BROWN, MARK T CLAREMONT BIOSOLUTIONS, LLC Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis Complete
2020 R43 PAR-18-303 ERVIN, ERIC ELECTRONIC BIOSCIENCES, INC. N6-Methyl-2-O-Methyladenosine Sequencing Active
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Active
2020 R43 PAR-18-303 WANG, SHA VIVID TECHNOLOGIES New specific and rapid assay for in situ apoptosis labeling for cancer studies Active
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2015 R43 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2014 R43 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
2014 R43 PAR-13-327 FELLMANN, CHRISTOF MIRIMUS, INC. RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO Complete
2014 R44 PAR-13-327 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2017 R43 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2017 R44 PAR-13-327 PREMSRIRUT, PREM KHOVABUTR MIRIMUS, INC. Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research Complete
2015 R43 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2015 R43 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2015 R43 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete
2015 R43 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete
2015 R43 PAR-13-327 TRAN, HIEP T ABZYME THERAPEUTICS, LLC HYBRIDOMA FREE MULTIPLEX APPROACH FOR ACCELERATING MOUSE MONOCLONAL ANTIBODY GENERATION Complete
2015 R43 PAR-13-327 MESSMER, BRADLEY T ABREOS BIOSCIENCES, INC. MULTIPLEXED DENANO PROTEIN ASSAY AND QUANTITATION: SEQUENCING BASED PROTEOMICS Complete
2015 R43 PAR-13-327 NEVO, EREZ ROBIN MEDICAL, INC. COMBINED OPTICAL AND MR MICROSCOPY SYSTEM FOR THIN TISSUE HISTOPATHOLOGY ANALYSIS Complete
2015 R43 PAR-13-327 MCCONNELL, TIMOTHY S ISOPLEXIS, INC. A SINGLE CELL MULTI-PROTEIN DEVICE TO FACILITATE CANCER IMMUNOTHERAPY Complete
2015 R43 PAR-13-327 SARAF, RAVI VAJRA INSTRUMENTS, INC. PROFILING CIRCULATING MIRNA WITHOUT PCR FOR EARLY DETECTION OF PANCREATIC CANCER Complete
2016 R43 PAR-13-327 OUELLETTE, STEVEN BRADLEY KINASENSE, LLC DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY Complete
2015 R43 PAR-13-327 ORBAI, LUCIAN CELL DATA SCIENCES, INC. RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS Complete
2016 R43 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2015 R43 PAR-13-327 EASTBURN, DENNIS J MISSION BIO, INC. MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING Complete
2003 R33 PAR-01-106 LIZARDI, PAUL M. YALE UNIVERSITY GENETIC ANALYSIS OF AMPLIFIED GENOMIC DNA ARCHIVES Complete
2003 R33 PAR-01-106 RONINSON, IGOR B ORDWAY RESEARCH INSTITUTE, INC. FUNCTION-BASED SELECTION OF TARGET GENES IN TUMOR CELLS Complete
2004 R44 PAR-01-106 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS Complete
2002 R33 PAR-01-106 SHAUGHNESSY, JOHN DAMIAN UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK MOLECULAR DIAGNOSIS AND PROGNOSIS OF MULTIPLE MYELOMA Complete
2002 R33 PAR-01-106 SCHNITZER, JAN EUGENIUSZ SIDNEY KIMMEL CANCER CENTER TECHNOLOGY TO UNMASK ACCESSIBLE TUMOR VASCULAR TARGETS Complete
2002 R21 PAR-01-106 BEITZ, ALVIN JAMES UNIVERSITY OF MINNESOTA TWIN CITIES IN VIVO ANALYSIS OF TUMOR PEPTIDE SECRETION Complete
2002 R21 PAR-01-106 DYNAN, WILLIAM S MEDICAL COLLEGE OF GEORGIA (MCG) LASER CAPTURE MICROSCOPY AND 2D-DIGE: CANCER PROTEOMICS Complete
2002 R21 PAR-01-106 SHIH, IE-MING JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF DIGITAL SNP ANALYSIS IN CANCER DETECTION Complete
2002 R21 PAR-01-106 GARCIA-BLANCO, MARIANO A. DUKE UNIVERSITY IMAGING ALTERNATIVE SPLICING DURING TUMOR PROGRESSION Complete
2002 R21 PAR-01-106 BAKER, LAURENCE HOWARD UNIVERSITY OF MICHIGAN AT ANN ARBOR MOLECULAR DIAGNOSIS OF SARCOMAS Complete
2004 R21 PAR-01-106 MAITRA, ANIRBAN JOHNS HOPKINS UNIVERSITY A SEQUENCING MICROARRAY FOR MITOCHONDRIAL MUTATIONS Complete
2002 R21 PAR-01-106 KENAN, DANIEL J. DUKE UNIVERSITY ENDOTHELIAL CELL MOLECULAR ALTERATIONS IN CANCER Complete
2004 R21 PAR-01-106 DE VERE WHITE, RALPH W. UNIVERSITY OF CALIFORNIA DAVIS YEAST ASSAY FOR P53 MOLECULAR ANALYSIS IN BLADDER CANCER Complete
2003 R21 PAR-01-106 LABAER, JOSHUA HARVARD UNIVERSITY (MEDICAL SCHOOL) FUNCTIONAL PROTEOMICS OF BREAST CANCER Complete
2002 R21 PAR-01-106 CHUONG, CHENG-MING UNIVERSITY OF SOUTHERN CALIFORNIA HIGH RESOLUTION MICROARRAY ANALYSIS OF CANCER Complete
2004 R21 PAR-01-106 SIMS, CHRISTOPHER E UNIVERSITY OF CALIFORNIA IRVINE ASSAYING TYROSINE KINASE ACTIVITY: A NEW PARADIGM Complete
2003 R21 PAR-01-106 ANGELETTI, RUTH HOGUE YESHIVA UNIVERSITY PROTEOMICS OF HEPATIC CARCINOGENESIS Complete
2002 R21 PAR-01-106 LEVENSON, VICTOR V NORTHWESTERN UNIVERSITY DNA METHYLATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA Complete
2004 R21 PAR-01-106 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS Complete
2004 R21 PAR-01-106 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON SINGLE CELL PROTEIN FINGERPRINTING - BARRETT'S ESOPHAGUS Complete
2003 R21 PAR-01-106 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO ENHANCED CRYSTALLOGRAPHY OF CANCER-IMPLICATED PROTEINS Complete

Pages